Key result
Elevated serum periostin and IL-6 were significant predictors of asthma, with periostin serving as an important biomarker for identifying the T2 inflammatory phenotype.
Why the study?
The study was conducted to assess the laboratory performance of periostin combined with a panel of biomarkers to identify the inflammatory phenotype of Brazilian asthma patients.
Does periostin identify the inflammatory phenotype in Brazilian asthma patients?
Cross-Sectional (n=103)
Yes
Does periostin identify the inflammatory phenotype in Brazilian asthma patients?
Periostin is an important biomarker for identifying the T2 inflammatory phenotype in asthmatic patients.
Answers are grounded in this paper and cite their sources.
Serum periostin panel may support asthma phenotyping in Brazilians; leaves open clinical utility pending validation.
OBJECTIVE: The aim of this study was to assess the laboratory performance of periostin associated with a panel of biomarkers to identify the inflammatory phenotype of Brazilian asthma patients. METHODS: We evaluated 103 Brazilian individuals, including 37 asthmatics and 66 nonasthmatic controls. Both groups underwent analyses for serum periostin, eosinophil levels in the peripheral blood, the fraction of exhaled nitric oxide (FeNO), total serum IgE, urinary leukotriene E4, and serum cytokines. RESULTS: Higher levels of periostin (p = 0.005), blood eosinophils (p = 0.012), FeNO (p = 0.001), total IgE (p < 0.001), and IL-6 (p ≤ 0.001) were found in the asthmatic patients than the controls. Biomarker analyses by the ROC curve showed an AUC greater than 65%. Periostin (OR: 12,550; 95% CI: 2,498-63,063) and IL-6 (OR: 7,249; 95% CI: 1,737-30,262) revealed to be suitable asthma inflammation biomarkers. Blood eosinophils, FeNO, total IgE, IL-6, TNF, and IFN-g showed correlations with clinical severity characteristics in asthmatic patients. Periostin showed higher values in T2 asthma (p = 0.006) and TNF in non-T2 asthma (p = 0.029). CONCLUSION: The panel of biomarkers proposed for the identification of the inflammatory phenotype of asthmatic patients demonstrated good performance. Periostin proved to be an important biomarker for the identification of T2 asthma.
No takes yet. Share an insight, caveat, or question.
Baldo et al. (2023) conducted a cross-sectional in Asthma (n=103). Elevated serum periostin vs. Non-asthmatic controls was evaluated on Identification of asthma (OR 12.55, 95% CI 2.498-63.063, p=0.005). Elevated serum periostin and IL-6 were significant predictors of asthma, with periostin serving as an important biomarker for identifying the T2 inflammatory phenotype.
Synapse has enriched 10 related papers. Consider them for comparative context: